To evaluate the efficacy and safety of secukinumab in Behçet's patients with active mucocutaneous and articular manifestations refractory to previous treatments.
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study / Di Scala, Gerardo; Bettiol, Alessandra; Cojan, Rafaela Diana; Finocchi, Martina; Silvestri, Elena; Emmi, Giacomo. - In: JOURNAL OF AUTOIMMUNITY. - ISSN 0896-8411. - ELETTRONICO. - 97:(2019), pp. 108-113. [10.1016/j.jaut.2018.09.002]
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study
Di Scala, GerardoMembro del Collaboration Group
;Bettiol, AlessandraMembro del Collaboration Group
;Cojan, Rafaela DianaMembro del Collaboration Group
;Finocchi, MartinaMembro del Collaboration Group
;Silvestri, ElenaMembro del Collaboration Group
;Emmi, Giacomo
2019
Abstract
To evaluate the efficacy and safety of secukinumab in Behçet's patients with active mucocutaneous and articular manifestations refractory to previous treatments.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
